Navigation Links
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
Date:4/7/2011

OSAKA, Japan and NORWOOD, Mass., April 7, 2011 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd. ("DSP") and Boston Biomedical, Inc. ("BBI"), today announced that they have signed a Product Option License Agreement for BBI608 for all oncology indications in Japan and exclusive right of negotiation for BBI608 for the United States and Canada.

BBI608 is an orally administered, first-in-class, small molecule anti-cancer drug that targets highly malignant cancer stem cells as well as other heterogeneous cancer cells. In clinical trials to date, BBI608 has shown excellent safety, favorable pharmacokinetics, and encouraging signs of anticancer activity.  BBI608 is under phase I extension clinical studies in colorectal cancer and phase Ib/II trials in multiple solid tumor types.

Under the terms of the agreement, BBI will receive $15million of upfront payment and clinical trial support upon signing.  Based on the outcome of the clinical trials, DSP has the option to acquire exclusive rights for the development and commercialization for BBI608 in Japan. In addition, DSP has an exclusive negotiation right for the United States and Canada for a certain time.  During this option agreement period, DSP will pay a maximum of $55million for part of the development costs of BBI608 and for continuation of the option. Assuming DSP exercise the option for Japan, upon successful clinical development and commercialization of BBI608 in Japan, BBI could receive a maximum of approximately $100million in aggregate, including milestone payments associated with successful development and commercialization, in addition to running royalties.

Masayo Tada, President and chief executive officer of DSP, said, "DSP recognizes oncology as an area with high unmet medical needs and has already spent substantial effort, defining it as a major specialty area. We are delighted to enter into this strategic partnership with Boston Biomedical in the oncology area to d
'/>"/>

SOURCE Boston Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
2. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
3. Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
4. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
5. CVS/pharmacy Debuts the "To Your Health" Program in Atlanta Bringing 60 Free Health Screening Events to the Community
6. CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste
7. Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit
8. Harnessing Patients Good Intentions Can Cut 33% of Americas Pharmacy-Related Waste
9. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
10. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
11. ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... recently published clinical study conducted at TOPS Comprehensive Breast ... that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls ... study, "Implementation of Breast Tomosynthesis in a Routine Screening ... Stephen L. Rose , MD, and published in ... Roentgenology (AJR). The AJR is the scientific journal ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... MINNEAPOLIS, Jan. 29 AGA Medical Corporation today launched ... Bruschi, a professional football player who suffered a stroke ... career. The unique online educational program will consist of ... Medical website that describe Tedy,s firsthand experience as a ...
... Jan. 28 Today at the American Academy of ... California at,San Diego report that no standardized practices ... Researchers looked at many factors,including: which steroids were ... a local anesthetic was mixed with the steroid. , ...
Cached Medicine Technology:AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 2AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 3Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain 2
(Date:5/25/2013)... (PRWEB) May 25, 2013 An experienced ... page in partnership with JD Media Surge, LLC. ... are now available and, depending on the treatment, can ... a routine visit, the best method will be chosen ... performed during a visit. A special peroxide-based whitening gel ...
(Date:5/25/2013)... News) -- Many viruses and parasites that affect both ... a bacteria-borne illness than can result in liver or ... according to a veterinarian. These germs could ... air, said Dr. Susan Nelson, a clinical associate professor ... these serious diseases can be fatal, even with treatment," ...
(Date:5/25/2013)... Providing patients with their best weight loss is ... management professionals. But, aside from educating patients on how to ... hCG diets also provide patients, who have gained weight ... more control over their lives by achieving their best weight ... factors of weight gain derived from earlier abuse, Diet Doc's ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 By working ... officially declared the integration of the 2012 Lamborghini Aventador ... is the latest entrant in the list of vehicles ... the vehicle is all set to thrill automobile lovers ... acceleration power and spectacular looks, the 2012 Lamborghini Aventador ...
(Date:5/25/2013)... May 25, 2013 According to world-renowned ... beautiful and powerful women that ever lived. Cleopatra’s legendary ... some of the most powerful men in her time. ... remedies to keep her skin glowing and fresh, from ... bees- wax, maringa oil and cyprus grass. , Cleopatra ...
Breaking Medicine News(10 mins):Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... Royer Animal Health, LLC, a wholly owned subsidiary ... agreement with MWI Veterinary, Supply, Inc. (Nasdaq: ... MATRIX III CISPLATIN BEADS and R-GEL ... products provide veterinary professionals with localized treatment options for ...
... of protests in Washington urging inclusion of the Community ... Impact points to the success of existing community-based, affordable ... number of those who need more intense health care ... million people with disabilities in the U.S., there is ...
... SCOTT DEPOT, W.Va., April 30 International Coal Group, Inc. (NYSE: ... the lead Pink Ribbon sponsor for the 2009 Susan G. Komen ... is scheduled to start at 9 a.m. in front of the ... honors the late Susan G. Komen, who died of breast cancer ...
... 30 SynCare, LLC, today announced it was awarded ... HealthCare USA members in Missouri. HealthCare USA engaged SynCare ... membership into appropriate case management programs.HealthCare USA is a ... Medicaid and SCHIP members. Their mission is to improve ...
... The Providence Service Corporation (Nasdaq: PRSC ... results for its first quarter ended March 31, 2009 on ... a conference call at 11:00 a.m. EDT (9:00 a.m. MDT ... to discuss its financial results and corporate developments. Interested ...
... McEntee praises Obama request for $1.5 billion in additional ... union survey of more than 100 health care facilities ... prepared to protect workers, health and safety during an ... In Peril: Preparing to Protect Worker Health and Safety ...
Cached Medicine News:Health News:Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections 2Health News:Community Approach Necessary For Affordable Long-Term Care, Says NCB Capital Impact 2Health News:SynCare, LLC(TM) Awarded HealthCare USA Health Risk Assessments Contract 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 3Health News:Union Survey on Influenza Pandemic Finds Lack of Adequate Health and Safety Measures for Health Care Workers 2Health News:Union Survey on Influenza Pandemic Finds Lack of Adequate Health and Safety Measures for Health Care Workers 3
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
The SURGIWIP™ suture ligature with delivery system is indicated for use in gynecologic, general and other abdominal and thoracic endoscopic procedures where a suture is appropriate for the endo...
Surgitie&trade Single Use Ligating Loops without Delivery System with POLYSORB™....
Medicine Products: